Low yield of genetic testing for known vascular connective tissue disorders in patients with fibromuscular dysplasia

Patients with fibromuscular dysplasia (FMD) may have clinical features consistent with Mendelian vascular connective tissue disorders. The yield of genetic testing for these disorders among patients with FMD has not been determined. A total of 216 consecutive patients with FMD were identified. Clinical characteristics were collected and genetic test results reviewed for abnormalities in the following genes: transforming growth factor-β receptor 1 and 2 (TGFβR1 and TGFβR2), collagen 3A1, fibrillin-1, smooth muscle α-actin 2, and SMAD3. A total of 63 patients (63/216; 29.2%) were referred for genetic counseling with testing performed in 35 (35/63; 55.6%). The percentage of patients with a history of arterial or aortic dissection, history of aortic aneurysm, systemic features of a connective tissue disorder, and a family history of sudden death was significantly larger in the group that underwent genetic testing (62.9% vs 18.2%, p < 0.001; 8.6% vs 1.7%, p = 0.02; 51.4% vs 17.1%, p < 0.001; and 42.9% vs 22.7%, p = 0.04, respectively). Two patients were found to have distinct variants in the TGFβR1 gene (c.611 C>T, p.Thr204lle and c.1285 T>C, p.Tyr429His). The yield of genetic testing for vascular connective tissue disorders was low in a high-risk subset of FMD patients. However, two patients with a similar phenotype had novel and distinct variants in the TGFβR1 gene, a finding which merits further investigation.

[1]  G. Bollini,et al.  Siblings with vascular involvement associated with hereditary multiples exostosis. , 2013, Journal of pediatric orthopedics. Part B.

[2]  Paul Coucke,et al.  Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGFβ signaling in FTAAD. , 2013, International journal of cardiology.

[3]  K. Eagle,et al.  The United States Registry for Fibromuscular Dysplasia: Results in the First 447 Patients , 2012, Circulation.

[4]  G. Pals,et al.  Phenotypic spectrum of the SMAD3-related aneurysms–osteoarthritis syndrome , 2011, Journal of Medical Genetics.

[5]  M. Rieder,et al.  Exome Sequencing Identifies SMAD3 Mutations as a Cause of Familial Thoracic Aortic Aneurysm and Dissection With Intracranial and Other Arterial Aneurysms , 2011, Circulation research.

[6]  A. Woolf,et al.  Renal FMD may not confer a familial hypertensive risk nor is it caused by ACTA2 mutations , 2011, Pediatric Nephrology.

[7]  J. Olin,et al.  Diagnosis, management, and future developments of fibromuscular dysplasia. , 2011, Journal of vascular surgery.

[8]  G. Vriend,et al.  Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis , 2011, Nature Genetics.

[9]  M. Ajduk,et al.  Pseudoaneurysm of the popliteal artery in a patient with multiple hereditary exostoses. , 2011, Annals of vascular surgery.

[10]  Deborah L. Thompson,et al.  Successful Outcome in Pregnancy With Arterial Tortuosity Syndrome , 2009, Obstetrics and gynecology.

[11]  Robert K. Yu,et al.  Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. , 2009, American journal of human genetics.

[12]  C. Holten,et al.  Hypertension in two sisters caused by so-called fibromuscular hyperplasia of the renal arteries. , 2009, Acta Medica Scandinavica.

[13]  C. Junien,et al.  Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype‐phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys‐Dietz syndrome and related disorders , 2008, Human mutation.

[14]  Timothy B Sackton,et al.  Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissections , 2007, Nature Genetics.

[15]  C. Bonaïti‐pellié,et al.  Inheritance of arterial lesions in renal fibromuscular dysplasia , 2007, Journal of Human Hypertension.

[16]  P. Byers,et al.  Aneurysm syndromes caused by mutations in the TGF-beta receptor. , 2006, The New England journal of medicine.

[17]  George H. Thomas,et al.  Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .

[18]  H. Dietz,et al.  Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome , 2006, Nature Genetics.

[19]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[20]  C. Catsman-Berrevoets,et al.  Three new families with arterial tortuosity syndrome , 2004, American journal of medical genetics. Part A.

[21]  J. Olin,et al.  Fibromuscular dysplasia. , 2004, The New England journal of medicine.

[22]  M. Stowasser,et al.  Polymorphisms of the renin-angiotensin system in patients with multifocal renal arterial fibromuscular dysplasia , 2001, Journal of Human Hypertension.

[23]  M. Stowasser,et al.  Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia , 2000, Journal of Human Hypertension.

[24]  R. Bigazzi,et al.  Bilateral fibromuscular dysplasia in identical twins. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  X. Jeunemaître,et al.  [Genetic study of renal artery fibromuscular dysplasia]. , 1998, Archives des maladies du coeur et des vaisseaux.

[26]  J. Parisi,et al.  Fibromuscular dysplasia of the internal carotid artery associated with α1-antitrypsin deficiency , 1998 .

[27]  E. Dmitrovsky,et al.  Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. , 1998, Cancer research.

[28]  D. Grange,et al.  Familial syndrome of progressive arterial occlusive disease consistent with fibromuscular dysplasia, hypertension, congenital cardiac defects, bone fragility, brachysyndactyly, and learning disabilities. , 1998, American journal of medical genetics.

[29]  M. Reiss,et al.  Cloning and genomic organization of the human transforming growth factor-beta type I receptor gene. , 1997, Genomics.

[30]  X. Jeunemaître,et al.  Possible familial origin of multifocal renal artery fibromuscular dysplasia , 1997, Journal of hypertension.

[31]  J. Parisi,et al.  Giant intracranial aneurysm and fibromuscular dysplasia in an adolescent with α1-antitrypsin deficiency: Case report , 1996 .

[32]  W. Schievink,et al.  Coexistence of Fibromuscular Dysplasia and Cystic Medial Necrosis in a Patient With Marfan's Syndrome and Bilateral Carotid Artery Dissections , 1994, Stroke.

[33]  J. Parisi,et al.  Arterial Fibromuscular Dysplasia Associated With Severe α1-Antitrypsin Deficiency , 1994 .

[34]  P. Whelton,et al.  Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. , 1989, Hypertension.

[35]  M. Limburg,et al.  Angiographic abnormalities mimicking fibromuscular dysplasia in a patient with Ehlers-Danlos syndrome, type IV. , 1989, Neurosurgery.

[36]  M. Yamakado,et al.  Clinical Significance of Cerebral Aneurysm in Renovascular Hypertension due to Fibromuscular Dysplasia: Two Cases in Siblings , 1989, Angiology.

[37]  K. Ericson,et al.  Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. , 1982, Stroke.

[38]  K. Gladstien,et al.  Penetrance estimates and recurrence risks for fibromuscular dysplasia , 1980, Clinical genetics.

[39]  A. Rushton.  The genetics of fibromuscular dysplasia. , 1980, Archives of internal medicine.

[40]  P. Cartier,et al.  Hereditary fibromuscular dysplasia with renovascular hypertension. , 1977, Annals of internal medicine.

[41]  W. Fry,et al.  Arterial fibrodysplasia. Histopathologic character and current etiologic concepts. , 1975, Archives of surgery.

[42]  G. Sánchez Torres,et al.  [Fibromuscular dysplasia: a genetic entity related to Ehlers-Danlos syndrome]. , 1974, Archivos del Instituto de Cardiologia de Mexico.

[43]  Harrison Eg,et al.  Pathologic classification of renal arterial disease in renovascular hypertension. , 1971 .

[44]  P. E. Bernatz,et al.  Morphology of fibromuscular dysplasia of the renal artery in renovascular hypertension. , 1967, The American journal of medicine.

[45]  H. Dustan,et al.  A pathologic-arteriographic correlation of renal arterial disease. , 1966, American heart journal.

[46]  M. Viamonte,et al.  Renal-artery abnormalities in three hypertensive sisters. Probable familial fibromuscular hyperplasia. , 1965, JAMA.

[47]  J. Olin,et al.  Fibromuscular dysplasia , 2000, Current opinion in rheumatology.

[48]  J. Parisi,et al.  Giant intracranial aneurysm and fibromuscular dysplasia in an adolescent with alpha 1-antitrypsin deficiency. , 1996, Journal of neurosurgery.

[49]  J. Parisi,et al.  Arterial fibromuscular dysplasia associated with severe alpha 1-antitrypsin deficiency. , 1994, Mayo Clinic proceedings.

[50]  M. Sporn,et al.  Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). , 1993, Growth factors.

[51]  M. Sporn,et al.  Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β) , 1993 .

[52]  M. Robinson,et al.  Familial fibromuscular dysplasia presenting as sudden death. , 1988, The American journal of cardiovascular pathology.

[53]  Robinson Mj,et al.  Familial fibromuscular dysplasia presenting as sudden death. , 1988 .

[54]  W. Ehrenfeld,et al.  Fibromuscular dysplasia of the internal carotid artery. , 1974, Archives of surgery.